Prostate Health Test Shown to Reduce Biopsy Procedures
A recent study has demonstrated that physicians elected to perform fewer biopsies when prostate health index testing was included in their overall clinical assessment.
Read MorePosted by Elaine Sanchez Wilson | Feb 6, 2018 | Research |
A recent study has demonstrated that physicians elected to perform fewer biopsies when prostate health index testing was included in their overall clinical assessment.
Read MorePosted by Cassandra Perez | Oct 17, 2017 | Cancer |
Megakaryocytes’ presence in prostate cancer linked to patient survival; such cells potentially have role in all cancer types.
Read MorePosted by Elaine Sanchez Wilson | May 2, 2017 | Cancer, Molecular Diagnostics |
Color’s 30-gene test for hereditary cancer and Cynvenio’s next-generation sequencing breast cancer test are now offered as a unified solution for assessing breast cancer risk with cost-effective patient monitoring.
Read MorePosted by Elaine Sanchez Wilson | Nov 1, 2016 | Research |
The studies will examine whether large-scale RNA profiling can predict a patient’s response to first- or second-line treatments in bladder, kidney, and prostate cancers.
Read MorePosted by Elaine Sanchez Wilson | Mar 21, 2016 | Research |
Researchers hope to spur development of a blood test that can be used to diagnose a variety of cancers at early stages.
Read More